Long-term use of adalimumab in the treatment of rheumatic diseases

Charalampos Papagoras, Paraskevi V Voulgari, Alexandros A DrososRheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, GreeceAbstract: Adalimumab, a fully humanized monoclonal antibody against tumor necrosis factor-alpha (TNF&alph...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Charalampos Papagoras, Paraskevi V Voulgari, Alexandros A Drosos
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://doaj.org/article/43f28b6a51da4deab3b66a59004132da
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!